380 related articles for article (PubMed ID: 2536399)
1. Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats.
Willenbrock RC; Tremblay J; Garcia R; Hamet P
J Clin Invest; 1989 Feb; 83(2):482-9. PubMed ID: 2536399
[TBL] [Abstract][Full Text] [Related]
2. Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
Hamet P; Tremblay J; Pang SC; Skuherska R; Schiffrin EL; Garcia R; Cantin M; Genest J; Palmour R; Ervin FR
J Hypertens Suppl; 1986 Jun; 4(2):S49-56. PubMed ID: 2873213
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
Leitman DC; Murad F
Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
[TBL] [Abstract][Full Text] [Related]
4. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic factor, the kidney and high blood pressure.
Hamet P; Tremblay J
Clin Invest Med; 1989 Oct; 12(5):329-35. PubMed ID: 2532087
[TBL] [Abstract][Full Text] [Related]
6. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
7. Biochemical mechanisms of atrial natriuretic factor action.
Tremblay J; Hamet P
Can J Physiol Pharmacol; 1989 Sep; 67(9):1124-9. PubMed ID: 2574629
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.
Yokota N; Bruneau BG; Kuroski de Bold ML; de Bold AJ
J Clin Invest; 1994 Nov; 94(5):1938-46. PubMed ID: 7962539
[TBL] [Abstract][Full Text] [Related]
9. The peripheral action of clonidine analog ST-91: involvement of atrial natriuretic factor.
Gutkowska J; Mukaddam-Daher S; Tremblay J
J Pharmacol Exp Ther; 1997 May; 281(2):670-6. PubMed ID: 9152372
[TBL] [Abstract][Full Text] [Related]
10. Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats.
Nonoguchi H; Knepper MA; Manganiello VC
J Clin Invest; 1987 Feb; 79(2):500-7. PubMed ID: 3027127
[TBL] [Abstract][Full Text] [Related]
11. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
Zavala L; Barbella Y; Israel A
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
[TBL] [Abstract][Full Text] [Related]
12. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
Cahill PA; Hassid A
J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
[TBL] [Abstract][Full Text] [Related]
13. Effects of atrial natriuretic factor on renal function and cyclic GMP production.
Blaine EH; Seymour AA; Marsh EA; Napier MA
Fed Proc; 1986 Jun; 45(7):2122-7. PubMed ID: 2872085
[TBL] [Abstract][Full Text] [Related]
14. Metoclopramide does not inhibit atrial natriuretic factor-stimulated diuresis in man.
Farrow S; Mahayni A; Banta G; Sowers J; Lockette W
Aviat Space Environ Med; 1996 Mar; 67(3):248-52. PubMed ID: 8775403
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.
Féthière J; De Léan A
Mol Pharmacol; 1991 Dec; 40(6):915-22. PubMed ID: 1684636
[TBL] [Abstract][Full Text] [Related]
16. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
[TBL] [Abstract][Full Text] [Related]
17. Thiorphan-induced natriuresis in volume-expanded rats: roles of endogenous atrial natriuretic factor and kinins.
Bralet J; Mossiat C; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1991 Sep; 258(3):807-11. PubMed ID: 1653839
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.
von Geldern TW; Budzik GP; Dillon TP; Holleman WH; Holst MA; Kiso Y; Novosad EI; Opgenorth TJ; Rockway TW; Thomas AM
Mol Pharmacol; 1990 Dec; 38(6):771-8. PubMed ID: 2174500
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of action and catabolism of atrial natriuretic factor in cultured human and animal kidney cells].
Ardaillou R; Dussaule JC; Chansel D; Prie D; Ardaillou N; Ronco P
Bull Acad Natl Med; 1992 Jun; 176(6):769-81; discussion 781-2. PubMed ID: 1464027
[TBL] [Abstract][Full Text] [Related]
20. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
Murad F; Waldman S; Molina C; Bennett B; Leitman D
Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
